Sharecare, Inc. (SHCR)
- Previous Close
0.7431 - Open
0.7465 - Bid 0.8040 x 1000
- Ask 0.8128 x 500
- Day's Range
0.7465 - 0.8183 - 52 Week Range
0.4810 - 1.8000 - Volume
1,550,079 - Avg. Volume
1,902,504 - Market Cap (intraday)
290.443M - Beta (5Y Monthly) 0.26
- PE Ratio (TTM)
-- - EPS (TTM)
-0.3600 - Earnings Date May 9, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
1.92
Sharecare, Inc. operates as a digital healthcare platform company. Its Sharecare platform connects people, patients, providers, employers, health plans, government organizations, and communities that optimize individual and population-wide well-being. The company offers enterprise solutions based on a software-as-a-service model that allows enterprise clients to message, motivate, and manage their populations, as well as measure their population progress; a suite of data and information-driven solutions; and life sciences solutions, which provides members with personalized information, programs, and resources to improve their health and well-being. It also operates RealAge, a platform for health assessment to assess behaviors and existing conditions of its members and provide metric for their physical health. In addition, the company provides secure, automated release of information, audit, and business consulting services to streamline the medical records process for medical facilities. It sells its solutions through direct sales organization and partner relationships. Sharecare, Inc. was founded in 2009 and is headquartered in Atlanta, Georgia.
www.sharecare.com3,352
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: SHCR
Performance Overview: SHCR
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SHCR
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SHCR
Valuation Measures
Market Cap
290.44M
Enterprise Value
164.60M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.64
Price/Book (mrq)
0.68
Enterprise Value/Revenue
0.37
Enterprise Value/EBITDA
-2.63
Financial Highlights
Profitability and Income Statement
Profit Margin
-28.86%
Return on Assets (ttm)
-12.65%
Return on Equity (ttm)
-24.33%
Revenue (ttm)
445.25M
Net Income Avi to Common (ttm)
-128.5M
Diluted EPS (ttm)
-0.3600
Balance Sheet and Cash Flow
Total Cash (mrq)
128.19M
Total Debt/Equity (mrq)
1.72%
Levered Free Cash Flow (ttm)
15.06M